Bioorganic & Medicinal Chemistry Letters 2010-04-01

Discovery of a novel selective PPARgamma modulator from (-)-Cercosporamide derivatives.

Akihiro Furukawa, Tsuyoshi Arita, Susumu Satoh, Kenji Wakabayashi, Shinko Hayashi, Yumi Matsui, Kazushi Araki, Masanori Kuroha, Jun Ohsumi

Index: Bioorg. Med. Chem. Lett. 20(7) , 2095-8, (2010)

Full Text: HTML

Abstract

In an investigation of (-)-Cercosporamide derivatives with a plasma glucose-lowering effect, we found that N-benzylcarboxamide derivative 4 was a partial agonist of PPARgamma. A SAR study of the substituents on carboxamide nitrogen afforded the N-(1-naphthyl)methylcarboxamide derivative 23 as the most potent selective PPARgamma modulator. An X-ray crystallography study revealed that compound 23 bounded to the PPARgamma ligand binding domain in a unique way without any interaction with helix12. Compound 23 displayed a potent plasma glucose-lowering effect in db/db mice without the undesirable increase in body fluid and heart weight that is typically observed when PPARgamma full agonists are administrated.2010 Elsevier Ltd. All rights reserved.

Related Compounds

  • Cercosporamide

Related Articles:

Bioactive metabolites from Phoma species, an endophytic fungus from the Chinese medicinal plant Arisaema erubescens.

2012-02-01

[Appl. Microbiol. Biotechnol. 93(3) , 1231-9, (2012)]

Inhibition of Mnk kinase activity by cercosporamide and suppressive effects on acute myeloid leukemia precursors.

2013-05-02

[Blood 121(18) , 3675-81, (2013)]

Cloning and characterization of KNR4, a yeast gene involved in (1,3)-beta-glucan synthesis.

1994-02-01

[Mol. Cell. Biol. 14(2) , 1017-25, (1994)]

Fermentative production of self-toxic fungal secondary metabolites.

2010-04-01

[J. Ind. Microbiol. Biotechnol. 37(4) , 335-40, (2010)]

Synthesis and biological evaluation of novel (-)-Cercosporamide derivatives as potent selective PPARγ modulators.

2012-08-01

[Eur. J. Med. Chem. 54 , 522-33, (2012)]

More Articles...